Inara India Pharmaceuticals Private Limited, a active private limited company, was established on 10 March 2017 in Kolkata, West Bengal, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74999WB2017PTC219889. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Imtiyaz Alam (Director), Akash Poddar (Director). Past directors included Suraj Kumar Kejriwal. It holds ₹0.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at P-58, Bangur Avenue Block -D, Kolkata, West Bengal, 700055.
U74999WB2017PTC219889
219889
10 March 2017
₹1.00 M
₹0.10 M
Roc Kolkata
Unlisted
Active
Explore comprehensive insights into Inara India Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Imtiyaz Alam | Director | 01 Feb 2023 | Current |
| Akash Poddar | Director | 10 Mar 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Mar 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Inara India Pharmaceuticals Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 32.81% increase. The company also saw a substantial improvement in profitability, with a 1347.6% increase in profit. The company's net worth Soared by an impressive increase of 24.2%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Inara India Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Oct 2019 | Idbi Bank Limited | ₹0.50 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Inara India Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Inara India Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inara India Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Imtiyaz Alam was appointed as a Director was appointed as a Director on 01 Feb 2023 & has been associated with this company since 2 years 9 months . was documented.
Inara India Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was recorded as a recent event.
The activity Inara India Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Kolkata. was completed.
A charge with Idbi Bank Limited amounted to Rs. 0.50 M with Charge ID 100310072 was registered on 25 Oct 2019. was recorded as a recent event.
The activity Akash Poddar was appointed as a Director was appointed as a Director on 10 Mar 2017 & has been associated with this company since 8 years 8 months . was completed.
Inara India Pharmaceuticals Private Limited was registered on 10 Mar 2017 with Roc Kolkata & aged 8 years 8 months as per MCA records. was recorded as a recent event.
The CIN of Inara India Pharmaceuticals Private Limited is U74999WB2017PTC219889.
Inara India Pharmaceuticals Private Limited is headquartered at P-58, Bangur Avenue Block -D, Kolkata, West Bengal, 700055.
Inara India Pharmaceuticals Private Limited was incorporated on 10 March 2017.
The current directors of Inara India Pharmaceuticals Private Limited are
The primary industry of Inara India Pharmaceuticals Private Limited is Trade.
Inara India Pharmaceuticals Private Limited is unlisted.
The authorized capital of Inara India Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Inara India Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX